Skip to main content

Table 1 Baseline characteristics (n = 41)

From: Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction – a prospective CMR study

Demographics

 Age, year

60 (50–67)

 Gender, male

34 (83)

 Body mass index, kg/m2

27 (24–30)

Cardiovascular risk factors

 Dyslipidemia

35 (85)

 Hypertension

14 (34)

 Diabetes

8 (20)

 Smoking

16 (39)

 Family risk for coronary artery disease

25 (61)

ST-elevation myocardial infarction

33 (81)

Culprit coronary artery

 Left anterior descending (or left main)

24 (59)

 Circumflex artery

5 (12)

 Right coronary

12 (29)

Multiple vessel disease

19 (46)

Anterior infarct

24 (59)

Method of reperfusion

 Thrombolysis

2 (5)

 Primary percutaneus coronary intervention

35 (85)

 Coronary artery bypass graft

4 (10)

Peak CK-MB (μg/L)

86 (40–216)

Discharge medication

 Aspirin

38 (93)

 Clopidogrel

37 (90)

 Beta blocker

40 (98)

 ACE-inhibitor/AT2-blocker

26 (63)

 Statin

40 (98)

 Diuretic

3 (7)

 Nitrate

1 (2)

 Warfarin

2 (5)

  1. Values are median (interquartile range) or n (%)